Next, we investigated if BK124.1 induces apoptosis in another type of CML cell population particularly resistant to chemotherapy, i.e., in the CML CD34+ stem and progenitor cells from patients (Figure 5). The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.